Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cardillo

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Recenti Progressi in Medicina|August 2, 2023
Alessandro C Rosa, Marco Finocchietti, Arianna Bellini, et al.
Diabetes|January 1, 2013
Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetesLorenzo Piemonti, Matthew J Everly, Paola Maffi, et al.
Frontiers in Medicine|December 19, 2022
Anti-glutathione S-transferase theta 1 antibodies correlate with graft loss in non-sensitized pediatric kidney recipientsPatrizia Comoli, Michela Cioni, Bryan Ray, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 5, 2018
Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective studyMichela Cioni, Arcangelo Nocera, Augusto Tagliamacco, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 24, 2026
Uncontrolled donation after circulatory death lung transplantation program: Clinical outcomes and perspectives for implementationAlessandro Palleschi, Alberto Zanella, Marco Sacchi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 1, 2021
Liver transplantation from active COVID-19 donors: A lifesaving opportunity worth grasping?Renato Romagnoli, Salvatore Gruttadauria, Giuseppe Tisone, et al.
Journal of Immunology Research|April 4, 2017
De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney RecipientsMichela Cioni, Arcangelo Nocera, Annalisa Innocente, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 21, 2025
Exploring auxiliary liver transplantation in the era of transplant oncology-A proposal for a new liver splitting program (ALERT-50)Enrico Gringeri, Alessandro Furlanetto, Marina Polacco, et al.
Transplantation Direct|October 29, 2021
The 3-T Model of Informed Consent for Nonstandard Risk Donors: A Proposal for Transplant Clinical PracticeAlessandra Agnese Grossi, Federico Nicoli, Tullia Maria De Feo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 7, 2006
Split and whole liver transplantation outcomes: a comparative cohort studyMassimo Cardillo, Nicola De Fazio, Paola Pedotti, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Recenti Progressi in Medicina|August 2, 2023
Alessandro C Rosa, Marco Finocchietti, Arianna Bellini, et al.
Diabetes|January 1, 2013
Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetesLorenzo Piemonti, Matthew J Everly, Paola Maffi, et al.
Frontiers in Medicine|December 19, 2022
Anti-glutathione S-transferase theta 1 antibodies correlate with graft loss in non-sensitized pediatric kidney recipientsPatrizia Comoli, Michela Cioni, Bryan Ray, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 5, 2018
Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective studyMichela Cioni, Arcangelo Nocera, Augusto Tagliamacco, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 24, 2026
Uncontrolled donation after circulatory death lung transplantation program: Clinical outcomes and perspectives for implementationAlessandro Palleschi, Alberto Zanella, Marco Sacchi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 1, 2021
Liver transplantation from active COVID-19 donors: A lifesaving opportunity worth grasping?Renato Romagnoli, Salvatore Gruttadauria, Giuseppe Tisone, et al.
Journal of Immunology Research|April 4, 2017
De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney RecipientsMichela Cioni, Arcangelo Nocera, Annalisa Innocente, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 21, 2025
Exploring auxiliary liver transplantation in the era of transplant oncology-A proposal for a new liver splitting program (ALERT-50)Enrico Gringeri, Alessandro Furlanetto, Marina Polacco, et al.
Transplantation Direct|October 29, 2021
The 3-T Model of Informed Consent for Nonstandard Risk Donors: A Proposal for Transplant Clinical PracticeAlessandra Agnese Grossi, Federico Nicoli, Tullia Maria De Feo, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 7, 2006
Split and whole liver transplantation outcomes: a comparative cohort studyMassimo Cardillo, Nicola De Fazio, Paola Pedotti, et al.
Pageof 12